Found 194 of ec50 data for polymerid = 50004660,50006396 TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 4nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 6nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 6nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 7nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 11nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 11nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 13nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 21nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 23nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 30nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 34nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 58nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 76nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 group M subtyp...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
